Introduction
Salinomycin was originally used as an anticoccidial drug in poultry, and for efficient nutrient absorption in piggery. Its preferential toxicity towards cancer-stem cells was described by Gupta and colleagues in the end of the last decade [1] . Salinomycin's toxicity towards cancer stem cells was further supported by recent studies in gastrointestinal sarcoma, osteosarcoma, and colorectal and breast cancers [2] [3] [4] . Even though the cell death mechanisms induced by Salinomycin still remain elusive, a recent study by Lu et al. shows that Salinomycin targets cancer stem cells by blocking Wnt/β-catenin pathway, which is critical for stem cell self renewal [5] . While Salinomycin is relatively non-toxic to primary cells, Boehmerle et al., show that Salinomycin induced cell death is through conventional caspase mediated apoptotic pathways [6] . Our own experiments (please see below) show that Salinomycin preferentially kills cancer cells.
Cellular house-keeping, homeostatic mechanism autophagy includes macroautophagy (bulk degradation including cellular organelles), microautophagy (uptake of cytoplasm for degradation) and chaperone mediated autophagy (CMA) (protein specific degradation) [7] [8] [9] . In the presence of growth factors autophagy is inhibited by the activation of PI3K/Akt pathway through activation of mTOR (mammalian target of rapamycin) [10, 11] . However, under nutrient deprivation or stress, inhibition of mTOR initiates phagophore formation through nucleation complex of autophagy involving ULK1/2, Beclin1 and other molecules. Several Autophagy Related Gene (ATG) family members ATG3, ATG5, ATG7, ATG12 etc., carry on further elongation of phagophore to form autophagosome [10, 12] . Autophagosomes carry dysfunctional cellular organelles (mitochondria, peroxisomes, ribosomes etc.) for degradation by fusing with lysosomes. More recent studies show alternative autophagic pathway independent of ULK, ATG5 and ATG7 mediated mechanism-requiring Beclin1 [10, 13, 14] . Organelle specific autophagy has been reported for mitochondria (mitophagy), endoplasmic reticulum (ER-phagy), ribosomes (Ribophagy) etc., as a mechanism to remove the dysfunctional organelles, or as a response to stress triggered by cytoplasmic overload with damaged organelles [15] .
Mitochondria, commonly called the powerhouses of the cell, form a dynamic interconnected network of tubular structures that are engaged in fission and fusion processes [16] . Mitochondrial fission is mediated by localization of Drp1 on the mitochondrial site of division whereas fusion is mediated by mitofusin proteins (mitofusins 1 and 2) along with OPA1 [17] . Lack of both mitofusin 1 (Mfn1) and mitofusin 2 (Mfn2) leads to impaired mitochondrial fusion but both of them can compensate each others loss [18] [19] [20] [21] . Under the event of stress or any event leading to dysfunction of normal mitochondria, the organelle undergoes an asymmetric, protective fission, that aims to spare at least part of stressed mitochondria, by splitting the organelle into a normally-functioning part, and a dysfunctional one. The process allows for subsequent degradation of dysfunctional mitochondria created in such a way, while sparing the functional ones.
Rehman and colleagues have recently described that cancer cells often have much smaller, fragmented mitochondria as compared to normal cells [22] . In the same study they show that cancer cells express an increased level of Drp1 and decreased level of Mfn protein, promoting a constant mitochondrial fission with impaired fusion, resulting in a smaller fragmented mitochondria in cancer cells [22] . Modification of the level of expression of Drp1 or Mfn in cancer cells decreased their proliferation, thus indicating that targeting of molecules regulating mitochondrial dynamics and function is a potentially novel target for cancer therapy [22] .
The maintenance of mitochondrial inner membrane potential is crucial for both ATP production and functions related to the induction of apoptosis. Opening of the outer mitochondrial membrane permeability transition pore (PTP) leads to cytochrome c release from the inter-membrane space of the mitochondria along with depolarization of the inner membrane and thus subsequently inhibiting the ATP production [23, 24] . However it is argued that the mitochondrial membrane potential has to be maintained for the release of cytochrome c and further apoptotic signaling cascade to occur [25, 26] . Others propose the mitochondrial hyperpolarization and thus mitochondrial condensation during apoptosis induction [27, 28] . Irrespective of the mechanism, mitochondrial release of cytochrome c into the cytosol is the trigger and component for the formation of apoptosome that leads to the activation of caspase cascade. Along with apoptosis, autophagy may under certain circumstances act as an alternative cell death mechanism [29] .
In this study, we have been investigating the mechanism of Salinomycin anticancer toxicity. Here we show that Salinomycin induces autophagy, and mitophagy. The autophagic response is a cell protective mechanism in prostate and breast cancer cells. We also report the critical role of Salinomycin in increasing the mitochondrial membrane potential (hyperpolarization) and activation of a programmed cell death through the differential activation of caspases among cancer cells. Our experimental data indicate that Salinomycin-triggered depletion of cellular ATP, in cancer cells but not in primary cells, contributes towards Salinomycin's preferential anticancer toxicity.
Materials and methods

Cells and cell culture
Prostrate cancer cell line (PC3), breast cancer cell lines (SKBR3 and MDAMB468) and murine embryonic fibroblast (MEF) cells, all available at our lab's cell bank, were cultured in RPMI media with 10% FBS and 1% penicillin-streptomycin antibiotics. MEF-ATG5 −/− described previously [30] , and human normal dermal fibroblasts, provided by Dr. Kratz [31] , were cultured in DMEM media with 10% FBS and 1% penicillin. All the cell lines were maintained at a confluence of~70%.
Materials and reagents
Salinomycin, Rapamycin, Bafilomycin, Chloroquine, Pepstatin and ED-64 were obtained from Sigma-Aldrich and dissolved in their respective buffers as per required concentrations. Rabbit-anti-LC3b, rabbitanti-HMGB1, and murine anti-actin were also from Sigma-Aldrich whereas rabbit-anti-ATG5 was obtained from Cellular Signaling Inc. The secondary antibodies anti-rabbit HRP-conjugate and anti-murine HRP-conjugates were obtained from Sigma-Aldrich and anti-rabbitAlexafluor488 and -594 were purchased from Life Technologies Ltd. MitoTracker Red CMXRos, LysoTracker Red DND-99, and MitoTracker Green FM were also purchased from Life Technologies Ltd.
Transmission electron microscopy (TEM)
Cells were initially fixed with 2% Glutaraldehyde in 0.1 M Sodiumcacodylate-HCl buffer with 0.1 M sucrose, (pH 7.4) for 2 h at 4°C and post fixed with 1% OsO 4 in 0.15 M Sodium -cacodylate-HCl buffer for 1 h. Cells were dehydrated in ethanol gradually and embedded in Epon 812. Ultrathin sections were cut on a Reichert Ultracut S Ultramicrotome, mounted on copper grids, air-dried, and further stained with uranyl acetate and lead citrate. Sections were examined and photographed with JEOL JEM 1230 electron microscope at 100 kV [29] .
MTT assay
100 μl of cells diluted at a concentration of 10 5 cells/ml were plated to each well of a 96 well plate and incubated in a humidified CO 2 chamber for 24 h. The next day, cells were treated as per respective experimental conditions (please see Results section and figure legends for details). After indicated time periods of treatments, 10 μl of 5 mg/ml 3-(4,5-dimethyl-2-thiazolyl) 2,5-diphenyl-2H tetrazolium bromide (MTT) solution (Sigma-Aldrich) was added to each well, incubated for 3 h and centrifuged at 90 g for 10 min. The supernatant was removed and the formed farmazan-crystals were dissolved in a solution containing equal volumes of DMSO:ethanol. The readings were taken at both 570 and 630 nm.
Po-Pro and 7-AAD cell death assay
Cells treated with or without Salinomycin at mentioned concentrations for the respective time periods were trypsinized and collected by centrifugation at 400 g for 5 min. The pelleted cells were resuspended in PBS and treated with Po-Pro and 7-AAD dyes (Life Technologies Ltd.) for 30 min as per manufacturer's instructions and analyzed using flow cytometer (Gallios, Beckman Coulter Inc.). Flow cytometry results were analyzed using Kaluza analysis software (Beckman Coulter Inc.).
Western blotting
Cells were lysed using RIPA buffer with Protease inhibitors (cOmplete Roche) and centrifuged to remove the debris. Cell lysates were loaded into a 12% polyacrylamide gel and ran at 100 V for 3 h and then transferred on to a PVDF membrane for 1 h at 100 V. The membrane was blocked with 5% milk protein and treated with primary antibodies overnight. The membrane is washed with 3× TBST and treated with respective secondary antibody for 1 h. The membrane is further washed with 3× TBST before developing using Amersham ECL plus Western blotting developing kit (GE Technologies). To analyze HMGB1 release the cellular supernatant was collected and an equal amount of the supernatant was loaded into a 15% gel and Western blotting was conducted as described above [32] .
Immunocytochemistry
Cells plated on cover-slips in a 12-well plate were washed with PBS after their respective treatment and fixed using 4% paraformaldehyde for 20 min at 4°C and rinsed twice with PBS for 5 min. The cells were then placed in incubation buffer (0.1% saponin and 5% FBS in PBS) for 20 min at room temperature and then treated with primary antibody (overnight at 4°C) and respective secondary antibody with conjugated fluorophore (1 h at room temp.) intervened by 3× washing with incubation buffer. The cells were washed and then mounted on a slide with a mounting medium containing DAPI. Images were taken using Laser Scanning Confocal Microscope (Zeiss).
LC3 staining, LysoTracker count and mitochondrial count and size
Immunofluorescent images of the cells treated with and without Salinomycin and stained for LC3, LysoTracker, and MitoTracker probes as per the manufacturer's protocol were analyzed by ImageJ software subtracting the background, using threshold and analyzing particle modules as described in a previous study [22] . A total of 30 cells from each experiment are analyzed for LC3 positive cell count and a total of 10 cells were counted for the number of LC3 fluorescent dots and LysoTracker count. Mitochondrial size and count are analyzed using images taken at 3 random locations in each of the control and Salinomycin treated samples. To further determine the influence of autophagy on mitochondrial number the cells are selected based on LC3 positivity as mentioned above.
Mitochondrial membrane potential and mass measurement
Mitochondrial activity was measured with JC1 assay kit (Sigma-Aldrich). 200× JC1 stock solution was diluted with distilled water and 5× JC1 staining buffer as per the requirements to make 1× JC1 solution and is added to the cells either in suspension (for flow cytometry) or attached to the plate (fluorimetry) and incubated for 20 min at a 37°C incubator. The cells were washed 2× with respective media and fluorescence was measured using a flow cytometer using FL1 and FL2 channels (Gallios, Beckman Coulter Inc.) or fluorescence plate reader (Victor3V, PerkinElmer) and images were taken using a confocal microscope (Zeiss). To further support the JC1 assay the same analysis using flow cytometry was performed with MitoTracker Green FM (localized to mitochondrial membrane and thus determine mitochondrial mass) and MitoTracker Red CMXRos that localizes to the matrix of the functional mitochondria with intact mitochondrial membrane potential (indicates mitochondrial function) as mentioned previously. 
ATP assay
Cells treated with Salinomycin for the respective time periods were washed with ice-cold PBS and treated with 100 μl of ATP releasing agent (Sigma-Aldrich) for 5 min and 50 μl of the extract was added into a light protected 96-well plate that was preloaded with 100 μl of ATP assay mix solution (Sigma-Aldrich) and incubated for 3 min at room temp. Immediately the luminescence was measured using luminescence plate reader (Victor3V, PerkinElmer).
Caspase activity assays
Caspase-3 activity and mitochondrial function were assessed using NucView 488 and MitoView 633 (Biotium). Samples were prepared similarly as Po-Pro assay as described above and treated with NucView 488 and MitoView 633 and kept on ice for 1 h before analyzing with flow cytometer (Gallios). Caspase-8 and -9 were analyzed using Green FLICA and Red FLICA caspase assay kits respectively from ImmunoChemistry Technologies. The cells were incubated at 37°C for 1 h before taking the fluorescence, which was measured in FL1 and FL4 using Gallios flow cytometer (Beckman Coulter Inc.).
Statistics
All the statistics (one way ANOVA) were conducted using Prism (version 6.0b) software and SPSS (IBM version 20) software. A P value of less than 0.05 is considered statistically significant unless mentioned otherwise.
Results
Salinomycin induces autophagy
Initial observations of 10 μM Salinomycin treated cells indicate a profound increase in vacuolization in breast cancer SKBR3 and MDAMB468 cell lines, and to lesser degree in prostate cancer PC3 cells, upon 24 h treatment (Fig. 1A) . The vacuolization is much less pronounced in human normal dermal fibroblasts. To investigate possible autophagosome formation levels of autophagic marker LC3II were monitored in SKBR3, MDAMB468 and PC3 cells. As shown in Fig. 1B , Salinomycin treated cells have an increased level of LC3I lipidation and LC3II formation with different concentrations of Salinomycin (1 μM, 2.5 μM and 10 μM) at 24 and 48 h. Autophagy was also confirmed using immuno-cytochemistry (Fig. 1C, D (Fig. 1D) . Fig. 1C also shows a localization of active lysosomes (LysoTracker Red) and LC3 signal (green fluorescent dots) in the near vicinity (or colocalization) thus providing a strong evidence for an active autophagic mechanism. The relative number of lysosome increase (LysoTracker Red counts) per cell, is shown in Fig. 1E , whereas the relative number increase of LC3 signals per cell (increase in autophagosome formation relative to their controls), is shown in Fig. 1F .
To further support the increase in active autophagy in Salinomycintreated cells, LC3II-flux was monitored at different time periods in prostate and breast cancer cell lines along with autophagy inhibitor. As predicted, an increase in LC3II accumulation was observed in Salinomycin treated cells that are pretreated for 1 h with autophagy inhibitor 20 μM Chloroquine ( Fig. 2A, and Supplementary Fig. 2A ). Similar observations were made using other autophagic inhibitors (Bafilomycin and pepstatin-ED64 mix) (Supplementary data Fig. 2B ). Further validation of Salinomycin induced autophagic process was done by transmission electron microscopy ( Fig. 2B and Supplementary Fig. 3 ). Salinomycin induces strong vacuolization and autophagosome formation. In the inset (bottom row) the representative images of lysosomes, autophagosomes and complete autophagolysosomes are indicated.
Salinomycin triggered autophagy counteracts cell death in cancer cells
Since autophagy may promote either cell survival or cell death, we tested by an MTT assay if autophagy inhibition by Chloroquine potentiates, or inhibits Salinomycin's toxicity. Surprisingly, inhibition of autophagy with Chloroquine (20 μM, Cq) in Salinomycin (10 μM, Sal) treated cancer cells increased cell death in tested breast-and prostate cancer cell lines, however, in human normal dermal fibroblasts autophagy inhibition actually increased survival (Fig. 3A) . As shown in Fig. 3B , immortalized murine embryonic fibroblasts deficient in ATG5 (ATG5-KO), a crucial gene involved in autophagosome elongation, also show an increased cell death upon treatment with Salinomycin, as compared to the respective control wild-type fibroblasts (Fig. 3B) . mitochondria. Thus, in order to assess the function of mitochondria and its role in Salinomycin induced cell death JC1 assay was used to analyze mitochondrial membrane potential and mitochondrial mass as described previously [33] . Using JC1 assay we can assess the net mitochondrial mass, represented by green signal, and intact mitochondrial potential represented by the red signal. As shown in Fig. 4AB , unlike human normal dermal fibroblasts, cancer cells treated with Salinomycin respond with the increase of mitochondrial mass (increased green fluorescence). (Fig. 4C, D) to analyze changes in mitochondrial function shows that there is an increase in both JC1 green and red fluorescence in breast cancer cell lines (SKBR3 and MDAMB468) at 24 h and 48 h with the exception that MDAMB468 cells show decreased red fluorescence at 48 h but increased green fluorescence (Fig. 4D) . Prostate cancer PC3 cell lines show a strong increase in green fluorescence but no statistically significant changes in red fluorescence. Thus, Salinomycin treated cancer cells, when analyzed as a whole, show drastic increase in JC1 (green/ red) ratio (Fig. 4C) indicating a net increase in depolarized mitochondria. However, Fig. 4B clearly shows the appearance of subpopulation of cancer cells with a strong red signal (hyperpolarized mitochondria), upon Salinomycin treatment. In fibroblasts, JC1 red fluorescence does not change significantly under Salinomycin treatment at 24 h and 48 h, however green fluorescence shows a very significant decrease at 24 h and a partial decrease at 48 h thus causing a decrease in JC1 ratio initially with the signs of JC1 ratio recovery to normalcy by 48 h (Fig. 4E) . The observed changes in mitochondria by confocal fluorescence microscopy correspond in decreased expression of MFN2 and increased expression of DRP1 upon Salinomycin treatment, as shown by Western blot (Fig. 4F) .
Similar results were obtained using MitoTracker Green FM and MitoTracker Red CMXRos dyes that indicate similar parameters as that of JC1 green and JC1 red fluorescence respectively. As shown in Supplementary Fig. 4 , MitoTracker Red and MitoTracker Green signals increased in Salinomycin treated cells compared to the control cells. Consistent to the JC1 ratio data MitoTracker Green fluorescence increased more drastically compared to MitoTracker Red, thus further supporting a marked increase in mitochondrial mass combined with a significant, net decrease in mitochondrial polarity.
To gain further insight into the functional state of mitochondria, we measured ATP-levels in primary cells and cancer cells treated with Salinomycin. A steady decrease in the amount of ATP levels was observed in both prostate cancer PC3 cell line and breast cancer SKBR3 and MDAMB468 cells (Fig. 5 ) treated with 10 μM Salinomycin for 12, 24, 36 and 48 h. However, there was no such alteration observed in human normal dermal fibroblasts (Fig. 5) .
Salinomycin disrupts mitochondrial network and induces mitophagy
Salinomycin treated cells showed various mitochondrial abnormalities and mitoptotic changes (Fig. 6A, and Supplementary Fig.  6A ) [34] . Furthermore, EM-micrographs indicate that mitochondria (in addition to previously reported ER role in this capacity) may be the sources of membranes for the formation of autophagosomes, as a conspicuous number of mitochondria like structures showed encapsulated darkly stained lysosomal-like bodies ( Supplementary Fig. 6B ) [35] . Electron micrographs also showed relatively shorter mitochondria in the Salinomycin treated cells (Fig. 6A) , as compared to the more elongated mitochondria in respective control non-treated cells. A manual count of total mitochondria per cell using electron micrographs also showed a decrease in the number of mitochondria with intact morphological features (Fig. 5B ). In accordance with the electron microscopy data, a careful analysis of confocal images obtained for treated and non-treated cancer cells stained with MitoTracker Red CMXRos indicates mitochondria with intact mitochondrial potential. Furthermore, we observe a lower number of mitochondria with increased size (Fig. 5C, D, and Supplementary Fig. 7 ) that may be indicative for mitochondrial swelling.
Mitochondrial autophagy was further confirmed by LC3 signal colocalization with the mitochondria (MitoTracker Red) in both primary and cancer cells treated with 10 μM Salinomycin (Fig. 6E) . In the same figure, Salinomycin treated cells show disruption in the mitochondrial network and relatively shorter mitochondria in fibroblasts and swollen or clumped mitochondria in cancer cell lines (Fig. 6E , and Supplementary  Fig. 8 ).
Salinomycin-induced cell death form, depends on drug's concentration
As indicated by MTT assay results (Fig. 7A ), Salinomycin induced a higher level of cell death in cancer cells as compared to human normal dermal fibroblasts (control). Since MTT assay does not distinguish between forms of cell death (it is a cell survival assay) we have next probed cell death induced by Salinomycin, using flow-cytometric 7AAD/Po-Pro assay that allows distinguishing between necrosis and apoptosis. As shown in Fig. 7B , cancer cells treated with lower concentration of Salinomycin (1 μM) show an increased number of early apoptotic cells (increase in only Po-Pro staining) and dead cells/necrotic cells (positive for Po-Pro and 7AAD stains). However, at higher concentration of Salinomycin (10 μM), along with apoptotic population, a significant number of cells show increased 7AAD staining without Po-Pro staining indicating a direct induction of necrotic cell death (Fig. 7B) . Salinomycin-induced necrosis was further confirmed by detecting HMGB1 in cell medium (HMGB1 normally resides in cell nucleus, if found in cell medium, it is considered a necrotic marker). Treatment of cancer cells with Salinomycin, increased medium content of HMGB1 in a dose-dependent manner (Fig. 7C) . Unlike in cancer cells, no marked increase in cell death was observed in human normal dermal fibroblasts treated with 10 μM Salinomycin (Fig. 7D ).
Salinomycin triggers caspase mediated apoptosis among the cells showing hyperpolarized mitochondria
We have previously shown (Fig. 4B ) that a subset of cancer cells treated with Salinomycin responds with mitochondrial hyperpolarization, rather than depolarization. Thus, we next checked the effects of Salinomycin on caspase-3 activity in our cell line models, while costaining them with MitoView 633 (indicator for polarized mitochondria). Flow-cytometric data indicate a significant increase in number of cells with increased mitochondrial polarization upon treatment with 1 μM Salinomycin for 24 h in SKBR3 and MDAMB468 cells (Fig. 8AB) . Surprisingly, we have observed a significant increase in caspase-3 activity predominantly in cells showing hyperpolarized mitochondria (MitoView 633-high) in Salinomycin treated cells compared to their controls (Fig. 8B) . Similarly, Salinomycin treated cells showed an increase in caspase-9 and caspase-8 activities compared to the controls (Fig. 8B) . Furthermore inhibition of caspase activity using a pan-caspase inhibitor quinoline-Val-Asp(Ome)-CH2-O-phenoxy (Q-VD-OPh, 10 μM) showed partial rescue from cell death by Salinomycin among SKBR3 cells (Fig. 8C ).
Discussion
Improving understanding of the biology of cancer, as well as new experimental drugs, like Salinomycin, that preferentially target cancer stem cells brings us closer to finding cure against this devastating group of diseases. Cancer biology is complicated and each type of cancer harbors its individual changes that may further evolve, once clinical therapy progresses. Still, some core aspects of cancer biology are prevalent in different forms of cancer. Among them are: (i) the presence of cancer stem cells (CSC) (tumor initiating cells) in (almost) every cancer, and (ii), set of metabolic changes, and anomalies in mitochondrial biology (Warburg effect), that make cancer metabolism largely dependent on glycolysis [36] . In this project, we focused on better understanding of the mechanism of Salinomycin toxicity, which as mentioned earlier [1] , preferentially kills cancer stem cells. We observed that Salinomycin triggered an increase in autophagy (as shown with the increased LC3 flux, number of lysosomes and formation of autophagolysosomes) in both, cancer cell lines (prostate and breast cancer cells) and primary cells (human normal dermal fibroblasts). The autophagy induced by Salinomycin was much stronger than by Rapamycin, which is typically used as a "positive control" for autophagy experiments. Salinomycin induced autophagy acts as a cell protective mechanism in cancer cells as ablation of autophagy with either autophagic inhibitors (Chloroquine) or experiments involving Salinomycin treatment of murine fibroblasts deficient in ATG5 (ATG5 −/− ) showed increased cell death. Interestingly, the increase of Salinomycin's toxicity upon autophagy inhibition was observed in breast and prostate cancer cells, but not in human normal dermal fibroblasts. This observation once again supports the popular understanding that autophagy is primarily a cell survival pathway, but if excessive, it may kill the cells [37] .
The molecular mechanism of Salinomycin's toxicity is complex and involves several effects. The increasing evidence of restoration to normal mitochondrial function and subsequent mitigation to promote oxidative phosphorylation as a means to meet cellular energy needs among cancer cells is considered an adequate move to overhaul their apoptotic resistance. In line to the role of mitochondria at the center of Salinomycin induced cell death we have observed several abnormal mitochondrial phenotypes and mitochondrial specific localization of autophagy marker LC3 indicating mitophagy. Mitochondrial tubular network showed disintegration along with fragmentation, the result of mitochondrial dynamics of fission and fusion, upon Salinomycin treatment. Both fission and fusion assist cellular stress rescue with mitochondrial fusion restoring the minimally damaged mitochondria and fission resulting in the cleavage of mitochondria followed by degradation of the damaged mitochondrial portion [16] . Similarly, Salinomycin treatment to cancer cells showed decreased number of mitochondria with intact inner membrane potential, increased staining for MitoTracker Red, a marker for intact inner mitochondrial membrane potential (ΔΨ) along with increased mitochondrial mass (marked by increased JC1 green fluorescence and MitoTracker Green FM). Moreover, there is no change in PGC1α protein expression, a major regulator for nuclear initiated mitochondrial biogenesis, upon treatment with Salinomycin in cancer cell lines ( Supplementary Fig. 9) ; thus, inferring that mitochondrial dynamic fusion and fission mechanisms contribute to the alterations in mitochondrial mass and maintenance of mitochondrial function in Salinomycin treated cells. While we interpret the increase of JC1 green fluorescence and MitoTracker Green staining as mitochondrial mass increase, one cannot fully exclude the possibility that the signal increase by both staining procedures is due to mitochondrial swelling.
Salinomycin treated cancer cells showed a decreased number of mitochondria with intact ΔΨ and increased staining for mitochondrial polarity in a subpopulation of cancer cells. We have also observed an increase in mitochondrial mass along with co-localization of LC3 with the mitochondria and TEM images showing various abnormal mitochondrial phenotypes. The dysfunctional mitochondria are either eliminated by mitophagy or contributed the membrane to autophagosomes to further encapsulate lysosomes and form autophago-lysosomes. This is an important pro-survival mechanism, since dysfunctional mitochondria may actually consume ATP, and/or generate excessive amounts of harmful reactive oxygen species, thus contributing to loss of cellular homeostasis [38] .
Similar to the hyperpolarization of mitochondria by Salinomycin in cancer cells, early studies using mitochondria isolated from rat liver Mitani et al., showed that Salinomycin increases release of K + ions from the mitochondria opposing the valinomycin induced depolarization of mitochondria by the uptake of K + ions [39] . In the same study Mitani et al., show that Salinomycin mediated inhibition of oxidative phosphorylation is K + ion dependent [39] . Likewise, in our current study cancer cells treated with Salinomycin showed depletion in total cellular ATP in a time and concentration dependent manner. ATP-depletion itself may be a strong autophagy-inducing stimulus, as the cell tries to restore its ATP-level [40, 41] . Mitochondrial hyperpolarization was also reported in staurosporine-, Fas-and p53-triggered apoptosis [25, 27, 28, 42, 43] . However, human normal dermal fibroblasts did not show such depletion in ATP upon treatment with Salinomycin. The observed cancer cell specific deleterious effect of Salinomycin is explained by the fact that cancer cells harbor various abnormalities within mitochondria, such as hyperpolarized mitochondria along with defective mitochondrial fission and fusion mechanisms due to the lack of functionally intact mitofusin proteins, DRP1 and other proteins involved in the mitochondrial dynamics [22, 44] . This compromised mitochondrial function among cancer cells could be the major contributor for the susceptibility of cancer cells to the ionic fluctuations induced by Salinomycin. Moreover, Dichloroacetate (DCA), which is also a K + ion channel modulator, and a molecule that preferentially targets cancer cells, contrasting to Salinomycin induces depolarization of mitochondria [44, 45] . Thus, ionic manipulation within mitochondria offers a unique target for the development of novel cancer therapies. Similar to staurosporine, Salinomycin also triggered activation of executioner caspase-3 along with initiator caspase-9, but only among the cells with hyperpolarized mitochondria. Inhibition of caspases using pan-caspase inhibitor Q-VD-OPh partially protected from cell death induced by Salinomycin but it was unable to fully reverse Salinomycin's toxic effect. Besides the activation of apoptotic signaling pathways, we also observed necrotic/necroptotic cell death, especially among cancer cells treated with higher concentrations (10 μM) of Salinomycin. A subpopulation of cells showed increased staining with 7-AAD, which in the used method preferentially stains necrotic cells, without any staining with an apoptotic marker (Po-Pro). Necrosis/necroptosis induction was also confirmed by the detection of HMGB1 protein (necrotic marker) [46, 47] in the extracellular supernatant of cells treated with higher concentrations of Salinomycin.
Numerous manuscripts published within the recent decade, clearly show that a number of cell death stimuli simultaneously activate apoptosis, necrosis (or necroptosis) and autophagy [8] . Apoptosis however, as the most specialized form of cell death usually prevails, not only due to its speed, but also because caspases actively cleave and eliminate elements of necrotic or autophagic machinery [15] . For example, caspases cleave and inactivate key elements of autophagic machinery, Beclin1, ATG4 and ATG5 [10, 29, 48] . Generated in the process fragments, i.e. the C-terminal Beclin1 fragment gains the ability to amplify mitochondrion-dependent apoptosis despite a lack of a BH3 domain [49] . Furthermore, Bcl2 anti-apoptotic proteins (Bcl2/Bcl-XL) can attach to Beclin1 and inhibit autophagy. Concomitantly, caspase-8 may block necrosis or necroptosis by the cleavage of RIPK1 and RIPK3, and thus, prevent the formation of a necrosome [50] .
In conclusion, this study shows that: (i) Salinomycin induces autophagy that initially has a protective effect in cancer cells, (ii) Salinomycin triggers mitochondrial swelling, mitophagy and disrupts mitochondrial architecture, (iii) cancer cell specific toxicity of Salinomycin is through mitochondrial hyperpolarization observed preferentially in cancer cells, (iv) Salinomycin induces both, caspase mediated apoptosis and necrosis/ necroptosis as evident by the release of HMGB1, and (v) Salinomycin caused strong and time-dependent ATP-depletion in cancer cells, but not in human normal dermal fibroblasts. Thus, specific and more robust toxicity of Salinomycin towards cancer and cancer stem cells without much adversity towards normal cells warrants the use of Salinomycin as an effective chemotherapeutic agent, in combination with autophagy inhibitors.
